TY - JOUR
T1 - Proceedings of a Sickle Cell Disease Ontology workshop — Towards the first comprehensive ontology for Sickle Cell Disease
AU - Mulder, Nicola
AU - Nembaware, Victoria
AU - Adekile, Adekunle
AU - Anie, Kofi A.
AU - Inusa, Baba
AU - Brown, Biobele
AU - Campbell, Andrew
AU - Chinenere, Furahini
AU - Chunda-Liyoka, Catherine
AU - Derebail, Vimal K.
AU - Geard, Amy
AU - Ghedira, Kais
AU - Hamilton, Carol M.
AU - Hanchard, Neil A.
AU - Haendel, Melissa
AU - Huggins, Wayne
AU - Ibrahim, Muntaser
AU - Jupp, Simon
AU - Kamga, Karen Kengne
AU - Knight-Madden, Jennifer
AU - Lopez-Sall, Philomène
AU - Mbiyavanga, Mamana
AU - Munube, Deogratias
AU - Nirenberg, Damian
AU - Nnodu, Obiageli
AU - Ofori-Acquah, Solomon Fiifi
AU - Ohene-Frempong, Kwaku
AU - Opap, Kenneth Babu
AU - Panji, Sumir
AU - Park, Miriam
AU - Pule, Gift
AU - Royal, Charmaine
AU - Sangeda, Raphael
AU - Tayo, Bamidele
AU - Treadwell, Marsha
AU - Tshilolo, Léon
AU - Wonkam, Ambroise
N1 - Funding Information:
The workshop was funded by the National Heart, Lung, and Blood Institute (NHLBI) , National Institutes of Health (NIH) as a supplement to the H3ABioNet grant. H3ABioNet is supported by the National Human Genome Research Institute (NHGRI) , Office of the Director (OD), NIH under award number U41HG006941 . The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Funding for two of the participants was provided by the National Human Genome Research Institute and the National Institute on Drug Abuse Genomic Resource Award: U41 HG007050 and the National Heart, Lung, and Blood Institute Supplement: U41HG007050-02S4 . We would like to thank Jade Hotchkiss who started the initial work on the ontology.
Publisher Copyright:
© 2016 The Authors
PY - 2016/3/1
Y1 - 2016/3/1
N2 - Sickle cell disease (SCD) is a debilitating single gene disorder caused by a single point mutation that results in physical deformation (i.e. sickling) of erythrocytes at reduced oxygen tensions. Up to 75% of SCD in newborns world-wide occurs in sub-Saharan Africa, where neonatal and childhood mortality from sickle cell related complications is high. While SCD research across the globe is tackling the disease on multiple fronts, advances have yet to significantly impact on the health and quality of life of SCD patients, due to lack of coordination of these disparate efforts. Ensuring data across studies is directly comparable through standardization is a necessary step towards realizing this goal. Such a standardization requires the development and implementation of a disease-specific ontology for SCD that is applicable globally. Ontology development is best achieved by bringing together experts in the domain to contribute their knowledge. The SCD community and H3ABioNet members joined forces at a recent SCD Ontology workshop to develop an ontology covering aspects of SCD under the classes: phenotype, diagnostics, therapeutics, quality of life, disease modifiers and disease stage. The aim of the workshop was for participants to contribute their expertise to development of the structure and contents of the SCD ontology. Here we describe the proceedings of the Sickle Cell Disease Ontology Workshop held in Cape Town South Africa in February 2016 and its outcomes. The objective of the workshop was to bring together experts in SCD from around the world to contribute their expertise to the development of various aspects of the SCD ontology.
AB - Sickle cell disease (SCD) is a debilitating single gene disorder caused by a single point mutation that results in physical deformation (i.e. sickling) of erythrocytes at reduced oxygen tensions. Up to 75% of SCD in newborns world-wide occurs in sub-Saharan Africa, where neonatal and childhood mortality from sickle cell related complications is high. While SCD research across the globe is tackling the disease on multiple fronts, advances have yet to significantly impact on the health and quality of life of SCD patients, due to lack of coordination of these disparate efforts. Ensuring data across studies is directly comparable through standardization is a necessary step towards realizing this goal. Such a standardization requires the development and implementation of a disease-specific ontology for SCD that is applicable globally. Ontology development is best achieved by bringing together experts in the domain to contribute their knowledge. The SCD community and H3ABioNet members joined forces at a recent SCD Ontology workshop to develop an ontology covering aspects of SCD under the classes: phenotype, diagnostics, therapeutics, quality of life, disease modifiers and disease stage. The aim of the workshop was for participants to contribute their expertise to development of the structure and contents of the SCD ontology. Here we describe the proceedings of the Sickle Cell Disease Ontology Workshop held in Cape Town South Africa in February 2016 and its outcomes. The objective of the workshop was to bring together experts in SCD from around the world to contribute their expertise to the development of various aspects of the SCD ontology.
UR - http://www.scopus.com/inward/record.url?scp=84961266681&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84961266681&partnerID=8YFLogxK
U2 - 10.1016/j.atg.2016.03.005
DO - 10.1016/j.atg.2016.03.005
M3 - Article
AN - SCOPUS:84961266681
SN - 2212-0661
VL - 9
SP - 23
EP - 29
JO - Applied and Translational Genomics
JF - Applied and Translational Genomics
ER -